Gene · 51592
Papers2,289
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,289
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spectrum of clinical phenotypes associated with myositis-specific and myositis-associated antibodies in juvenile idiopathic inflammatory myositis: Our experience from North India. | Semin Arthritis Rheum | 2026 | 41887030 | PubTator, text mining | PubMed |
| Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A. | PLoS One | 2026 | 41886499 | PubTator, text mining | PubMed |
| Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel Observation. | Antibodies (Basel) | 2026 | 41874029 | PubTator, text mining | PubMed |
| Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies. | J Autoimmun | 2026 | 41863861 | PubTator, text mining | PubMed |
| An entropy-initiated coupled-trait ODE framework for modeling longitudinal cohort dynamics. | PLoS One | 2026 | 41855272 | PubTator, text mining | PubMed |
| Fatal Cardiomyopathy Secondary to Seronegative Immune-Mediated Necrotizing Myopathy: A Case Report. | Am J Case Rep | 2026 | 41834235 | PubTator, text mining | PubMed |
Anti-PM/Scl Antibody-Positive Dermatomyositis With Rapidly Progressive Interstitial Lung Disease in a 19-Year-Old Male: Clinical Implications of a Presumptive Diagnosis Based on Line Immunoassay Positivity. | Cureus | 2026 | 41809306 | PubTator, text mining | PubMed |
| A Brain-Targeting Curcumin Analog Inhibits Glioblastoma Progression Through THBS1/TGF-β1/PI3K-AKT Axis Modulation: Evidence From Experimental and Bioinformatic Analyses. | J Cell Mol Med | 2026 | 41807988 | PubTator, text mining | PubMed |
| Lactylation as a metabolic-epigenetic switch in cancer: dual roles in cell death resistance and therapeutic vulnerability. | Cell Death Dis | 2026 | 41786683 | PubTator, text mining | PubMed |
| Dermatomyositis masquerading as angioedema: a crucial differential not to overlook. | BMJ Case Rep | 2026 | 41781005 | PubTator, text mining | PubMed |
| Recurrent anti-TIF1γ-positive dermatomyositis coexisting with postoperative parotid lymphoepithelial carcinoma: a case report with pathogenesis analysis. | Front Immunol | 2026 | 41777896 | PubTator, text mining | PubMed |
| Flagellate erythema and breast infiltration. | JAAD Case Rep | 2026 | 41777463 | PubTator, text mining | PubMed |
| Evaluating the Diagnostic Potential of Myxovirus Resistance Protein 1 (MX1) and Myxovirus Resistance Protein 2 (MX2) As Biomarkers in Idiopathic Inflammatory Myopathies. | Cureus | 2026 | 41769532 | PubTator, text mining | PubMed |
| Editorial: Immunomodulatory strategies for managing viral infections: host immune responses and therapeutic targets. | Front Cell Infect Microbiol | 2026 | 41769346 | PubTator, text mining | PubMed |
| Lactylation in urological malignancies: emerging mechanisms and therapeutic direction. | Front Cell Dev Biol | 2026 | 41768991 | PubTator, text mining | PubMed |
| Dermatomyositis: Prevalence, Clinical Spectrum, Diagnostic Approach, and Management Strategies. | Arch Intern Med Res | 2026 | 41768519 | PubTator, text mining | PubMed |
| Nailfold video capillaroscopy as a non-invasive biomarker in juvenile dermatomyositis: A longitudinal analysis of microvascular changes and clinical relevance over one year. | Semin Arthritis Rheum | 2026 | 41764972 | PubTator, text mining | PubMed |
| Periorbital heliotrope erythema with edema as a potential clinical marker of paraneoplastic Dermatomyositis - a case series. | J Dtsch Dermatol Ges | 2026 | 41762004 | PubTator, text mining | PubMed |
Distinct by Design: Unraveling the Unique Clinical and Transcriptomic Identity of Juvenile Scleromyositis Overlap Compared to Juvenile Systemic Sclerosis and Juvenile Dermatomyositis: Implications for Care and Pathogenesis. | ACR Open Rheumatol | 2026 | 41757646 | PubTator, text mining | PubMed |
| TRIM proteins as emerging regulators of immune pathways: potential therapeutic targets in immune-related disorders. | Front Immunol | 2026 | 41756277 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51592/papers?page=3